Artículos por temáticas

A feasibility study of conducting the Montreal Cognitive Assessment remotely in individuals with movement disorders.

Abdolahi A, Bull MT, Darwin KC, Venkataraman V, Grana MJ, Dorsey ER, Biglan KM.

Health Informatics J. 2016 Jun;22(2):304-11. doi: 10.1177/1460458214556373.

Lower urinary tract dysfunction in patients with functional movement disorders.

Batla A, Pareés I, Edwards MJ, Stamelou M, Bhatia KP, Panicker JN.

J Neurol Sci. 2016 Feb 15;361:192-4. doi: 10.1016/j.jns.2015.12.048.

The Effectiveness of Transcranial Brain Stimulation in Improving Clinical Signs of Hyperkinetic Movement Disorders.

Obeso I, Cerasa A, Quattrone A.

Front Neurosci. 2016 Jan 7;9:486. doi: 10.3389/fnins.2015.00486. Review.

Successful Treatment of Paroxysmal Movement Disorders of Infancy With Dimenhydrinate and Diphenhydramine.

Sawicka KM, Goez H, Huntsman RJ.

Pediatr Neurol. 2016 Mar;56:72-5. doi: 10.1016/j.pediatrneurol.2015.10.019.

Movement disorders: advances in 2015.

Hattori N.

Lancet Neurol. 2016 Jan;15(1):8-9. doi: 10.1016/S1474-4422(15)00362-2. Review. No abstract available.

Editorial on: Pagonabarraga J, Martinez-Hora S, Fernandez de Bobadilla R et al. Minor hallucinations occur in drug-naïve Parkinson's disease patients even from the premotor phase. Movement Disorders 2015; Available from: DOI: 10.1002/mds.26432.

Friedman JH.

Mov Disord. 2016 Jan;31(1):9-10. doi: 10.1002/mds.26472. No abstract available.

Transcranial sonography in movement disorders: an interesting tool for diagnostic perspectives.

Sanzaro E, Iemolo F.

Neurol Sci. 2016 Mar;37(3):373-6. doi: 10.1007/s10072-015-2424-6.

Movement Disorders in Non-Wilsonian Cirrhotic Patients: A Report of the Prevalence and Risk Factors from a Study Done in a Medical School in an Agricultural-Based Community.

Methawasin K, Chonmaitree P, Wongjitrat C, Rattanamongkolgul S, Asawavichienjinda T.

J Mov Disord. 2016 Jan;9(1):28-34. doi: 10.14802/jmd.15034.

Behçet disease presenting with movement disorders and antibasal ganglia antibodies.

Rizzo G, Licchetta L, Scaglione C, Buttiglione M, Capellari S, Martinelli P, Martino D.

Autoimmun Rev. 2016 Mar;15(3):287-8. doi: 10.1016/j.autrev.2015.11.011. No abstract available.

Same same but different: analyzing hyperkinetic movement disorders.

Himmelmann K.

Dev Med Child Neurol. 2016 Feb;58(2):113. doi: 10.1111/dmcn.12995. No abstract available.

Burke-Fahn-Marsden dystonia severity, Gross Motor, Manual Ability, and Communication Function Classification scales in childhood hyperkinetic movement disorders including cerebral palsy: a 'Rosetta Stone' study.

Elze MC, Gimeno H, Tustin K, Baker L, Lumsden DE, Hutton JL, Lin JP.

Dev Med Child Neurol. 2016 Feb;58(2):145-53. doi: 10.1111/dmcn.12965.

Evaluation of (99m)Tc-TRODAT-1 SPECT in the diagnosis of Parkinson's disease versus other progressive movement disorders.

Fallahi B, Esmaeili A, Beiki D, Oveisgharan S, Noorollahi-Moghaddam H, Erfani M, Tafakhori A, Rohani M, Fard-Esfahani A, Emami-Ardekani A, Geramifar P, Eftekhari M.

Ann Nucl Med. 2016 Feb;30(2):153-62. doi: 10.1007/s12149-015-1042-y.

Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine.

Wijemanne S, Jankovic J, Evans RW.

Headache. 2016 Jan;56(1):153-61. doi: 10.1111/head.12712. Erratum in: Headache. 2016 Mar;56(3):616.

Switching from constant voltage to constant current in deep brain stimulation: a multicenter experience of mixed implants for movement disorders.

Preda F, Cavandoli C, Lettieri C, Pilleri M, Antonini A, Eleopra R, Mondani M, Martinuzzi A, Sarubbo S, Ghisellini G, Trezza A, Cavallo MA, Landi A, Sensi M.

Eur J Neurol. 2016 Jan;23(1):190-5. doi: 10.1111/ene.12835.

High prevalence of genetic alterations in early-onset epileptic encephalopathies associated with infantile movement disorders.

Kobayashi Y, Tohyama J, Kato M, Akasaka N, Magara S, Kawashima H, Ohashi T, Shiraishi H, Nakashima M, Saitsu H, Matsumoto N.

Brain Dev. 2016 Mar;38(3):285-92. doi: 10.1016/j.braindev.2015.09.011.